Skip to main content

Chemed Inc(CHE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low368.49
Day High375.39
Open:371.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Chemed Inc

Select a category then submit the form to load news
StockStory
Q4 Earnings Outperformers: Chemed (NYSE:CHE) And The Rest Of The Senior Health, Home Health & Hospice Stocks
CHE
Tipranks
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Chemed (CHE) and PROCEPT BioRobotics (PRCT)
StockStory
3 Out-of-Favor Stocks Walking a Fine Line
FLO
StockStory
3 Reasons to Sell CHE and 1 Stock to Buy Instead
CHE
StockStory
1 Unpopular Stock That Deserves Some Love and 2 We Find Risky
UNF
GlobeNewswire
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference
Tipranks
How Targeted Tariffs Could Squeeze Chemed’s Margins Despite Its Domestic Focus
Tipranks
Chemed Earnings Call: Mixed Quarter, Back-Half 2026 Hopes
StockStory
Why Chemed (CHE) Shares Are Plunging Today
CHE
Motley Fool
Chemed (CHE) Q4 2025 Earnings Call Transcript
StockStory
Chemed (NYSE:CHE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops 14.7%
CHE
GlobeNewswire
Chemed Reports Fourth-Quarter 2025 Results
StockStory
Chemed (CHE) To Report Earnings Tomorrow: Here Is What To Expect
CHE
StockStory
1 Cash-Producing Stock to Consider Right Now and 2 We Find Risky
DNOW
StockStory
3 Reasons to Sell CHE and 1 Stock to Buy Instead
CHE
Motley Fool
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake
GlobeNewswire
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents
StockStory
1 Profitable Stock on Our Watchlist and 2 That Underwhelm
TOST
StockStory
3 Healthcare Stocks We Steer Clear Of
UFPT
TheNewswire.com
Cincinnati Plumbing Leader Marks 90 Years of Service
StockStory
1 Small-Cap Stock to Target This Week and 2 We Avoid
MATX
StockStory
3 Low-Volatility Stocks We Find Risky
CHE
Tipranks
Alphabet upgraded, Micron initiated: Wall Street’s top analyst calls
StockStory
Why Chemed (CHE) Shares Are Sliding Today
CHE
GlobeNewswire
Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
StockStory
1 of Wall Street’s Favorite Stock to Consider Right Now and 2 Facing Challenges
MRVL
Tipranks
RBC Capital Sticks to Its Buy Rating for Chemed (CHE)
Tipranks
Chemed (CHE) Receives a Buy from Bank of America Securities
Tipranks
Chemed (CHE) Receives a Buy from Jefferies
StockStory
3 Out-of-Favor Stocks We Think Twice About
UPLD
GlobeNewswire
Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference
StockStory
3 Small-Cap Stocks We Approach with Caution
FLYW

Profile

Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.